tirzepatide mechanism of action gip for diabetes: on track to SURPASS current therapy Major physiological roles of GLP-1

Understanding this distinction is essential when discussing tirzepatide, as patients often search for more affordable alternatives

It works by mimicking the hormone GLP-1 to help regulate appetite

Availability of data and materials All data generated or analyzed during this study are available from the corresponding author upon reasonable request

Vortioxetine had a dose-dependent risk of constipation at dosages above 20 mg/day (which is also the maximum recommended dose)

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound)